fda warning bpc 157 peptide unapproved Next week, July 23-24, the FDA's Pharmacy Compounding Advisory Committee will review seven peptides being considered for inclusion on the 503A Bulks List. Why does this matter? If these peptides are ultimately fda warning letter bpc-157 unapproved
Description
However: It can cause water retention, increased appetite, and insulin sensitivity changes in some users
Patient-Centered Approach: Your wellness goals are our priority
Some recent patients of mine have asked if they should be taking peptides, no less physicians in San Diego sending me emails about whats going on with peptides
Do not shake vigorously, as this creates air bubbles and can damage the peptide structure
